Recent News for DMAC - DiaMedica Therapeutics Inc.

Date Title
Nov 29 X, NVAX, PIR and SVRA among midday movers
Nov 14 DiaMedica Therapeutics Inc. 2019 Q3 - Results - Earnings Call Presentation
Nov 14 DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q3 2019 Results - Earnings Call Transcript
Nov 13 DiaMedica Therapeutics EPS beats by $0.01
Nov 13 DiaMedica Therapeutics Announces Third Quarter 2019 Financial Results and Provides Business Update
Nov 13 DiaMedica Therapeutics (DMAC) Investor Presentation - Slideshow
Nov 13 The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher
Nov 13 74 Biggest Movers From Yesterday
Nov 10 The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict
Nov 6 DiaMedica Therapeutics to Report Third Quarter 2019 Financials and Provide a Business Update November 14, 2019
Nov 5 DiaMedica Therapeutics to Participate in 10th Annual Craig-Hallum Alpha Select Conference
Oct 14 Healthcare - Top 5 Gainers / Losers
Oct 14 DiaMedica receives FDA clearance to initiate mid-stage DM199 trial for CKD
Oct 14 DiaMedica Therapeutics Announces Clearance to Initiate Phase II Clinical Trial of DM199 for Chronic Kidney Disease
Oct 9 The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug
Oct 7 Healthcare dominate midday movers
Sep 27 The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave
Sep 11 DiaMedica Therapeutics (DMAC) Presents At 4th Annual Dougherty & Company Institutional Investor Conference - Slideshow
Sep 6 DiaMedica Therapeutics to Present at Lake Street’s 3rd Annual Best Ideas Growth (BIG3) Conference on September 12, 2019
Sep 3 DiaMedica Therapeutics to Present at the 2019 Dougherty & Co. Institutional Investor Conference
Aug 15 Sintx Technologies leads healthcare gainers; Cytosorbents and Genetic Technologies among losers
Aug 15 The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings
Aug 15 61 Biggest Movers From Yesterday
Aug 14 DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q2 2019 Results - Earnings Call Transcript
Aug 14 Novavax and Akari Therapeutics among healthcare gainers; DelMar Pharmaceuticals leads the losers

Back to the Main DMAC Page...